Tekmira Pharmaceuticals Corporation (TKMR)
Add to Watchlists Create an Alert
4.71
-0.04 -0.80%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Tekmira Pharmaceuticals Corporation Cash and ST Investments:
47.03M for Dec. 31, 2012Tekmira Pharmaceuticals Corporation Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 47.03M |
| Sept. 30, 2012 | 5.744M |
| June 30, 2012 | 6.714M |
| March 31, 2012 | 8.777M |
| Dec. 31, 2011 | 9.001M |
| Sept. 30, 2011 | 8.911M |
| June 30, 2011 | 9.893M |
| March 31, 2011 | 9.473M |
| Dec. 31, 2010 | 12.35M |
| Sept. 30, 2010 | 15.44M |
| June 30, 2010 | 17.26M |
| March 31, 2010 | 18.18M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
TKMR Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Alnylam Pharmaceuticals | 236.01M |
| DelMar Pharmaceuticals | 0.004M |
| Arqule | 79.27M |
TKMR Cash and ST Investments Rankings
| Overall |
67th percentile 2617 of 8011 |
| Sector |
61st percentile 266 of 687 in Healthcare |
| Industry |
59th percentile 100 of 248 in Biotechnology |
TKMR Cash and ST Investments Range, Past 5 Years
| Minimum | 5.744M | Sep 2012 |
| Maximum | 47.03M | Dec 2012 |
| Average | 19.03M |
TKMR News
Tekmira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 14
Seeking Alpha May 14